Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

Similar Items

• Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)
  od: Shapiro, Lauren Q., i dr.
  Izdano: (2014)
• Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
  od: Hu, Ming-Hung, i dr.
  Izdano: (2014)
• Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
  od: Argiris, Athanassios, i dr.
  Izdano: (2010)
• A Phase II Trial of Bevacizumab + Cetuximab + Cisplatin with Concurrent Intensity Modulated Radiation Therapy (IMRT) for Patients with Stage III/IVB Head and Neck Squamous Cell Carcinoma (HNSCC)
  od: Fury, Matthew G., i dr.
  Izdano: (2015)
• A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinoma
  od: Wang, Bi-Cheng, i dr.
  Izdano: (2019)